CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
Published on March 6, 2019
March 6, 2019
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | Apollo Medical Holdings, Inc. |
Registration Statement on Form S-3
File No. 333-229895
VIA EDGAR
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Apollo Medical Holdings, Inc. (the “Registrant”) hereby respectfully requests that the effectiveness of the Registration Statement on Form S-3 (File No. 333-229895) of the Registrant (the “Registration Statement”) be accelerated so that it will be declared effective at 4:00 p.m., Eastern Standard Time, on March 8, 2019 or as soon thereafter as may be practicable.
The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, Shartsis Friese LLP, by calling P. Rupert Russell at (415) 421-6500. The Registrant hereby authorizes Mr. Russell to orally modify or withdraw this request for acceleration.
Very truly yours, | ||
APOLLO MEDICAL HOLDINGS, INC. | ||
By: | /s/ Warren Hosseinion, M.D. | |
Name: Warren Hosseinion, M.D. | ||
Title: Co-Chief Executive Officer |